Company Email Format Management

Seraxis

Biotechnology Research 20400 Century Blvd 26 employees

Employees: 26
Contacts: 2
Emails: 2
Phones: 1

seraxis.com LinkedIn Crunchbase

Seraxis Overview

Headquarters: 20400 Century Blvd
Website: seraxis.com
Industry: Biotechnology Research
Employees: 26
Founded: 2013
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Cell therapy Regenerative medicine Stem cells Type 1 Diabetes Organ replacement Functional endocrine pancreas Off-the-shelf implants

About Seraxis

Seraxis is bringing transformative therapies to the millions of people worldwide struggling with the management of insulin-requiring diabetes and the associated life-threatening complications. Seraxis’ lead program, SR-02, is a novel islet replacement therapy for patients of insulin-requiring diabetes with concurrent immunosuppression therapy. This therapy is the foundation of Seraxis follow-on therapies for patients without immune suppression. Frazier Life Sciences, Polaris Partners, Eli Lilly and Company, the T1D Fund and others are investors in Seraxis.

Seraxis Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Seraxis Org Chart

Sample employees and titles

Name	Title	Location	Contact
Dawn Gates	Pbm Industry Expert, Experienced Department of Defense Contract Negotiator and Financial Manager, Portfolio Management	St Louis, Missouri, United States	View
Giuseppe Orlando, Md, Phd, Marie Curie Fellow	Transplant Surgeon Scientist at Wake Forest University Health Sciences		View
Mohammad Razvi Md, PMP	Director Clinical Operations/clinical Operations Consulting/fractional	Washington Dc-baltimore Area, United States	Email
William L. Rust, Ph.d.	Chief Scientific Officer, President, Founder of Seraxis Inc.	Gaithersburg, Maryland, United States	Email Phone